Streetbeat News

Partnerships

AMPG

AmpliTech Group's AGTGSS division has entered into a 5-year supplier agreement with Fujitsu Spain to provide private 5G network products. This partnership could enhance AmpliTech's market presence in the 5G sector.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:33 pm

BIGC

NVEI

Nuvei has partnered with BigCommerce to provide integrated payment solutions, aiming to enhance omnichannel experiences for customers in North America, Europe, and APAC.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:32 pm

ACN

Accenture has invested in Reality Defender, a cybersecurity company specializing in deepfake detection, to help clients in various industries combat deepfake fraud. The terms of the investment were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:31 pm

BGNE

INDP

Indaptus Therapeutics has announced a clinical supply agreement with BeiGene to evaluate a novel cancer treatment combining BeiGene's tislelizumab and Indaptus' Decoy20. The trial is expected to start in 2025, with a conference call scheduled for October 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:20 pm

CMG

Chipotle has partnered with Paradox to introduce an AI hiring platform named 'Ava Cado' across its 3,500+ restaurants. This initiative aims to streamline recruitment processes by 75%, supporting the company's fall hiring efforts.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:17 pm

CORZ

Core Scientific has expanded its high-performance computing (HPC) hosting capacity as CoreWeave exercises its final contract option for an additional 120 MW. This brings the total contracted infrastructure to 500 MW, potentially boosting revenue to $8.7 billion over 12 years.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:16 pm

TWST

XOMA

Twist Bioscience has entered into a royalty purchase agreement with XOMA Corporation. XOMA will provide Twist with a $15 million upfront payment in exchange for the right to receive half of future potential milestones earned under Twist's antibody discovery and biopharma services collaborations.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:13 pm

CRWD

FTNT

CrowdStrike and Fortinet have formed a strategic partnership to integrate AI-native endpoint security with next-generation firewall protection, enhancing security across networks, applications, and endpoints.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:13 pm

GRFS

Grifols has partnered with BARDA to test ocular immunoglobulin eye drops for treating sulfur mustard-induced eye injuries. Success could lead to FDA approval, making it one of the first treatments for chemical warfare ocular damage. A Phase 2 trial for dry eye disease is planned for 2025.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:12 pm

AKBA

Akebia Therapeutics has signed a multi-year commercial contract with a leading kidney care provider to expand access to its drug Vafseo for dialysis patients. The drug is expected to be available in the U.S. by January 2025.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:10 pm